Cardiometabolic disease Clinical Trials

15 recruitingLast updated: May 11, 2026

There are 15 actively recruiting cardiometabolic disease clinical trials across 6 countries. Studies span Not Applicable, Phase 1. Top locations include Aventura, Florida, United States, Birmingham, Alabama, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Cardiometabolic disease Trials at a Glance

15 actively recruiting trials for cardiometabolic disease are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Aventura, Birmingham, and Boston. Lead sponsors running cardiometabolic disease studies include Helsinki University Central Hospital, Massachusetts General Hospital, and Amgen.

Browse cardiometabolic disease trials by phase

Treatments under study

About Cardiometabolic disease Clinical Trials

Looking for clinical trials for Cardiometabolic disease? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiometabolic disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiometabolic disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Cardiometabolic Disease and Substrate Metabolism

Insulin ResistancePregnancyPregnancy Complications+9 more
University of Tennessee Graduate School of Medicine50 enrolled1 locationNCT07565727
Recruiting
Not Applicable

Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity

Cardiometabolic DiseasesMultimorbidity
The University of Hong Kong240 enrolled3 locationsNCT07158697
Recruiting
Not Applicable

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Glucose metabolismExerciseObesity+4 more
University of Alabama at Birmingham200 enrolled1 locationNCT05216042
Recruiting
Not Applicable

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Heart FailureType 2 DiabetesDiabetic Cardiomyopathy+1 more
University of Texas Southwestern Medical Center300 enrolled1 locationNCT06593327
Recruiting
Phase 1

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

Cardiometabolic disease
Amgen80 enrolled5 locationsNCT06585462
Recruiting
Not Applicable

Sustainable Diets and Cardiometabolic Health

Cardiometabolic Diseases
University of Copenhagen180 enrolled1 locationNCT07189676
Recruiting
Not Applicable

Impact of Earplugs on Mechanisms of Noise-Related Cardiovascular Disease

Cardiometabolic DiseasesNoise exposure
Massachusetts General Hospital26 enrolled1 locationNCT07148817
Recruiting

Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)

SarcopeniaAgingAll Cause Mortality+2 more
RenJi Hospital10,000 enrolled1 locationNCT07205510
Recruiting
Not Applicable

Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program for Immigrant Communities of Brooklyn, NY

Cardiometabolic disease
NYU Langone Health100 enrolled1 locationNCT07076251
Recruiting

REal-world Data of CARdiometabolic ProtEcTion

Cardiometabolic Diseases
Sun Yat-sen University40,000 enrolled1 locationNCT07038083
Recruiting

Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study

Sleep-disordered breathing (SDB)Sleep ApneaCardiometabolic Diseases+2 more
Xiangya Hospital of Central South University15,000 enrolled1 locationNCT06755840
Recruiting

Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders

ObesityCardiometabolic Diseases
Helsinki University Central Hospital750 enrolled1 locationNCT05223530
Recruiting

PROMOTE Cohort Study: maternal & PeRinatal Outcomes aMongst wOmen with and without obEsity – a personalised and acceptable approach of risk assessment and stratification using social, clinical, nutritional and physical activity data

Large for gestational ageCardiometabolic diseaseObesity+2 more
Professor Dharmintra Pasupathy, Director, Reproduction and Perinatal Centre, University of Sydney1,000 enrolled1 locationACTRN12624001344583
Recruiting
Not Applicable

The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety

Cardiometabolic diseaseAnemia, Iron DeficiencyLow Iron Stores
University of Reading16 enrolled1 locationNCT06466746
Recruiting

Intervention Whyalla: Workplace health promotion for improving metabolic health and health awareness

Cardiometabolic diseaseType 2 Diabetes Mellitus
University of South Australia1,800 enrolled1 locationACTRN12612001171808